On a global level, less neutrophils in inflammatory infiltrates of the lungs, less MPO activity in these neutrophils, and less ROS-mediated resistance toward M. tuberculosis in mice as compared to humans may limit the effects of MPO inhibition in experimental murine tuberculosis and the usability of these mice to evaluate MPO-targeting therapies. The gene discussed is MPO; the disease is tuberculosis.